Evidence map›Paper›PMID 31026349›Full record

ArticleJournal of periodontology2019

Characterization of periodontitis in people with type 1 diabetes of 50 years or longer duration.

Takanori Shinjo, Atsushi Ishikado, Hatice Hasturk, David M Pober, Samantha M Paniagua, Hetal Shah, I-Hsien Wu, Liane J Tinsley, Motonobu Matsumoto, Hillary A Keenan and 3 more

Abstract read
In one paragraph

Article in Journal of periodontology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Early Biomarkers of Periodontitis: New Challenges for a Personalized Medicine Approach.International journal of environmental research and public health · 2021
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Takanori ShinjoSection of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA.
Atsushi IshikadoSection of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA.
Hatice HasturkCenter for Clinical and Translational Research, The Forsyth Institute, Cambridge, MA, USA.
David M PoberSection of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA.
Samantha M PaniaguaSection of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA.
Hetal ShahSection of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA.
I-Hsien WuSection of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA.
Liane J TinsleySection of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA.
Motonobu MatsumotoSection of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA.
Hillary A KeenanSanofi Genzyme, Cambridge, MA, USA.
Thomas E Van DykeCenter for Clinical and Translational Research, The Forsyth Institute, Cambridge, MA, USA.
Robert J GencoDepartment of Oral Biology, School of Dental Medicine, State University of New York at Buffalo, Buffalo, NY, USA.
George L KingSection of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA.
Harvard University · USJoslin Diabetes Center · USSanofi (United States) · USSunstar (Japan) · JPUniversity at Buffalo, State University of New York · US

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 1986 to 2026
$50.5M
Validation of Potential Protective Factors from Diabetic ComplicationsDP3DK094333 · NIDDK · JOSLIN DIABETES CENTER · PI KING, GEORGE L · 2011 to 2015
$4.1M
Identification of Retinoid-Binding Protein 3 (RBP3): A Protective Factor against Diabetic Retinopathy Using Retina from People with Extreme Duration of DiabetesR01EY026080 · NEI · JOSLIN DIABETES CENTER · PI KING, GEORGE L · 2016 to 2024
$3.1M
NEI NIH HHS R01 EY026080NIDDK NIH HHS DP3 DK094333NIDDK NIH HHS P30 DK036836NIH HHS P30DK036836
6 · The paper itself

Abstract

backgroundPeriodontitis is more common and severe in people with diabetes than the general population. We have reported in the Joslin Medalist Study that people with type 1 diabetes of ≥50 years (Medalists) may have endogenous protective factors against diabetic nephropathy and retinopathy.

methodsIn this cross-sectional study, the prevalence of periodontitis according to the Centers for Disease Control/American Academy of Periodontology classification in a subset (n = 170, mean age = 64.6 ± 6.9 years) of the Medalist cohort, and its associations to various criteria of periodontitis and diabetic complications were assessed.

resultsThe prevalence of severe periodontitis in Medalists was only 13.5% which was lower than reported levels in diabetic patients of similar ages. Periodontal parameters, including bleeding on probing, plaque index, gingival index, and demographic traits, including male sex, chronological age, and age at diagnosis were significantly associated with severity of periodontitis, which did not associate with diabetes duration, hemoglobin A1c (HbA1c), body mass index, and lipid profiles. Random serum C-peptide levels inversely associated with severity of periodontitis (P = 0.03), lower probing depth (P = 0.0002), and clinical attachment loss (P = 0.03). Prevalence of cardiovascular diseases (CVD) and systemic inflammatory markers, plasma interleukin-6 (IL-6), and serum immunoglobulin G titer against Porphyromonas gingivalis positively associated with severity of periodontitis (P = 0.002 and 0.02, respectively). Antibody titer to P. gingivalis correlated positively and significantly with CVD, serum IL-6, and high-sensitivity C-reactive protein.

conclusionsSome Medalists could be protected from severe periodontitis even with hyperglycemia. Endogenous protective factors for periodontitis could possibly be related to residual insulin production and lower levels of chronic inflammation.

Indexed as

Diabetes Mellitus, Type 1PeriodontitisAgedCross-Sectional StudiesDental Plaque IndexGlycated HemoglobinHumansMaleMiddle AgedPeriodontal Attachment LossGlycated Hemoglobincardiovascular diseasesdiabetesepidemiologyperiodontal medicineperiodontitis

Identifiers

PMID31026349
PMCPMC7087383
OpenAlexW2942111473

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.